Evolent Health, Inc.

Equities

EVH

US30050B1017

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:01 2024-04-18 pm EDT 5-day change 1st Jan Change
29.62 USD -0.07% Intraday chart for Evolent Health, Inc. -2.98% -10.32%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating MT
JPMorgan Trims Price Target on Evolent Health to $52 From $53, Maintains Overweight Rating MT
Transcript : Evolent Health, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 02:35 PM
Canaccord Genuity Cuts Price Target on Evolent Health to $45 From $47, Maintains Buy Rating MT
Evolent Health Q4 Adjusted Income, Revenue Rise; Q1, 2024 Revenue Guidance Set; Shares Jump After Hours MT
Transcript : Evolent Health, Inc., Q4 2023 Earnings Call, Feb 22, 2024
Earnings Flash (EVH) EVOLENT HEALTH Reports Q4 EPS $0.23, vs. Street Est of $0.15 MT
Earnings Flash (EVH) EVOLENT HEALTH Posts Q4 Revenue $556.1M, vs. Street Est of $542.9M MT
Evolent Health, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year Ending December 31, 2024 CI
Evolent Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Evolent Health, Inc. Announces Board Changes CI
Transcript : Evolent Health, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 03:45 PM
JMP Securities Initiates Evolent Health With Market Outperform Rating, Price Target is $37 MT
Evolent Health Plans $350 Million Convertible Senior Notes Offering; Shares Fall MT
Evolent Health Shares Drop on $350 Million Note Offering DJ
RBC Trims Price Target on Evolent Health to $42 From $44, Keeps Outperform Rating MT
Truist Securities Trims Price Target on Evolent Health to $34 From $36, Maintains Hold Rating MT
Transcript : Evolent Health, Inc., Q3 2023 Earnings Call, Nov 02, 2023
Earnings Flash (EVH) EVOLENT HEALTH Posts Q3 EPS $0.30 MT
Earnings Flash (EVH) EVOLENT HEALTH Reports Q3 Revenue $511M, vs. Street Est of $509.8M MT
Evolent Health, Inc. Provides Earnings Guidance for the Fourth Quarter Ending December 31, 2023 and Full Year 2023 CI
Evolent Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
UBS Starts Evolent Health With Buy Rating, Price Target is $46 MT
Insider Sell: Evolent Health MT
Transcript : Evolent Health, Inc., Q2 2023 Earnings Call, Aug 02, 2023
Chart Evolent Health, Inc.
More charts
Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
29.62 USD
Average target price
45.23 USD
Spread / Average Target
+52.70%
Consensus
  1. Stock Market
  2. Equities
  3. EVH Stock
  4. News Evolent Health, Inc.
  5. Evolent Health Reports Higher Q4 Earnings, Revenue; 2022 Revenue Guidance Issued